SANDRA COX: Open Payments
NPI 1215976220 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,279 in 53 payments from 18 companies in 2025. Trend: 2023 $1,207 · 2024 $1,337 · 2025 $1,279
Food & beverage: $1,180Education: $99
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $185 |
| Janssen Biotech, Inc. | 16 | $175 |
| E.R. Squibb & Sons, L.L.C. | 7 | $159 |
| Galderma Laboratories, L.P. | 1 | $150 |
| GENZYME CORPORATION | 4 | $138 |
| ABIOMED | 1 | $108 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $83 |
| Regeneron Healthcare Solutions, Inc. | 4 | $61 |
| Lilly USA, LLC | 2 | $35 |
| LEO Pharma Inc. | 2 | $31 |
Products named: DUPIXENT, TREMFYA, Sotyktu, NEMLUVIO, TAVNEOS, ILUMYA, OTEZLA, TALTZ.
Industry payments across KY — which companies pay providers there.
